Please Wait
Applying Filters...
menu
    • menu
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Sacubitril-Valsartan

    Virtual Booth

    Contact Supplier

    Bhavna Laboratories is an API & Intermediate manufacturer focusing on the muscle relaxant & ophthalmic segments.

    Virtual Booth

    Contact Supplier

    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Sacubitril-Valsartan

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-08-25

    Virtual Booth

    An Enquiry

    Menu

    Sacubitril-Valsartan

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 2,089Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 10Entresto

    PharmaCompass
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    01

    Brand Name : Entresto

    Sacubitril, Valsartan

    arrow
    ChemOutsourcing
    Not Confirmed

    Brand Name : Entresto

    Switzerland
    arrow
    ChemOutsourcing
    Not Confirmed

    Novartis

    Sacubitril, Valsartan

    Main Therapeutic Indication : Cardiovascular Diseases

    Currency : USD

    2020 Revenue in Millions : 2,497

    2019 Revenue in Millions : 1,726

    Growth (%) : 45

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    Brand Name : Entresto

    Sacubitril, Valsartan

    arrow
    ChemOutsourcing
    Not Confirmed

    Brand Name : Entresto

    Switzerland
    arrow
    ChemOutsourcing
    Not Confirmed

    Novartis

    Sacubitril, Valsartan

    Main Therapeutic Indication : Cardiovascular Diseases

    Currency : USD

    2021 Revenue in Millions : 3,548

    2020 Revenue in Millions : 2,497

    Growth (%) : 42

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    Brand Name : Entresto

    Sacubitril, Valsartan

    arrow
    ChemOutsourcing
    Not Confirmed

    Brand Name : Entresto

    Switzerland
    arrow
    ChemOutsourcing
    Not Confirmed

    Novartis

    Sacubitril, Valsartan

    Main Therapeutic Indication : Cardiology/Vascular Diseases

    Currency : USD

    2022 Revenue in Millions : 4,644

    2021 Revenue in Millions : 3,548

    Growth (%) : 31

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    Brand Name : Entresto

    Sacubitril, Valsartan

    arrow
    ChemOutsourcing
    Not Confirmed

    Brand Name : Entresto

    Switzerland
    arrow
    ChemOutsourcing
    Not Confirmed

    Novartis

    Sacubitril, Valsartan

    Main Therapeutic Indication : Cardiology/Vascular Diseases

    Currency : USD

    2023 Revenue in Millions : 6,035

    2022 Revenue in Millions : 4,644

    Growth (%) : 30

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    Brand Name : Entresto

    Sacubitril, Valsartan

    arrow
    ChemOutsourcing
    Not Confirmed

    Brand Name : Entresto

    Switzerland
    arrow
    ChemOutsourcing
    Not Confirmed

    Novartis

    Sacubitril, Valsartan

    Main Therapeutic Indication : Cardiology/Vascular Diseases

    Currency : USD

    2024 Revenue in Millions : 7,822

    2023 Revenue in Millions : 6,035

    Growth (%) : 30

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    06

    Brand Name : Entresto

    Sacubitril, Valsartan

    arrow
    ChemOutsourcing
    Not Confirmed

    Brand Name : Entresto

    Switzerland
    arrow
    ChemOutsourcing
    Not Confirmed

    Novartis

    Sacubitril, Valsartan

    Main Therapeutic Indication : Cardiovascular

    Currency : USD

    2015 Revenue in Millions : 0

    2014 Revenue in Millions : 21

    Growth (%) : New Launch

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    07

    Brand Name : Entresto

    Sacubitril, Valsartan

    arrow
    ChemOutsourcing
    Not Confirmed

    Brand Name : Entresto

    Switzerland
    arrow
    ChemOutsourcing
    Not Confirmed

    Novartis

    Sacubitril, Valsartan

    Main Therapeutic Indication : Cardiovascular Diseases

    Currency : USD

    2016 Revenue in Millions : 170

    2015 Revenue in Millions : 21

    Growth (%) : 710

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    08

    Brand Name : Entresto

    Sacubitril, Valsartan

    arrow
    ChemOutsourcing
    Not Confirmed

    Brand Name : Entresto

    Switzerland
    arrow
    ChemOutsourcing
    Not Confirmed

    Novartis

    Sacubitril, Valsartan

    Main Therapeutic Indication : Cardiovascular Diseases

    Currency : USD

    2017 Revenue in Millions : 507

    2016 Revenue in Millions : 170

    Growth (%) : 198

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    09

    Brand Name : Entresto

    Sacubitril, Valsartan

    arrow
    ChemOutsourcing
    Not Confirmed

    Brand Name : Entresto

    Switzerland
    arrow
    ChemOutsourcing
    Not Confirmed

    Novartis

    Sacubitril, Valsartan

    Main Therapeutic Indication : Cardiovascular Diseases

    Currency : USD

    2018 Revenue in Millions : 1,028

    2017 Revenue in Millions : 507

    Growth (%) : 103%

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    10

    Brand Name : Entresto

    Sacubitril, Valsartan

    arrow
    ChemOutsourcing
    Not Confirmed

    Brand Name : Entresto

    Switzerland
    arrow
    ChemOutsourcing
    Not Confirmed

    Novartis

    Sacubitril, Valsartan

    Main Therapeutic Indication : Cardiovascular Diseases

    Currency : USD

    2019 Revenue in Millions : 1,726

    2018 Revenue in Millions : 1,028

    Growth (%) : 68

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF